20.87
-0.29
(-1.37%)
At close: January 10 at 4:00:00 PM EST
20.87
0.00
(0.00%)
After hours: January 10 at 4:00:37 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | 0.29 | 0.31 | 1.29 | 1.34 |
| Low Estimate | 0.27 | 0.28 | 1.23 | 1.17 |
| High Estimate | 0.34 | 0.33 | 1.34 | 1.5 |
| Year Ago EPS | 0.6 | 0.55 | 2.36 | 1.29 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 242.83M | 245.25M | 990.28M | 1.01B |
| Low Estimate | 239M | 237.04M | 978.6M | 980.4M |
| High Estimate | 248.4M | 249.74M | 1.01B | 1.03B |
| Year Ago Sales | 334.75M | 342.6M | 1.35B | 990.28M |
| Sales Growth (year/est) | -27.46% | -28.42% | -26.45% | 1.82% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.57 | 0.48 | 0.49 | 0.25 |
| EPS Actual | 0.6 | 0.55 | 0.69 | 0.34 |
| Difference | 0.03 | 0.07 | 0.2 | 0.09 |
| Surprise % | 4.70% | 14.51% | 40.89% | 33.75% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.29 | 0.31 | 1.29 | 1.34 |
| 7 Days Ago | 0.29 | 0.31 | 1.29 | 1.34 |
| 30 Days Ago | 0.29 | 0.31 | 1.29 | 1.34 |
| 60 Days Ago | 0.29 | 0.3 | 1.21 | 1.26 |
| 90 Days Ago | 0.29 | 0.3 | 1.21 | 1.26 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | 2 | 4 | 9 | 8 |
| Down Last 7 Days | 1 | -- | -- | -- |
| Down Last 30 Days | 6 | 2 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PINC | -51.05% | -43.76% | -45.39% | 4.04% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Hold to Hold | 11/6/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 11/6/2024 |
| Maintains | Baird: Neutral to Neutral | 11/6/2024 |
| Maintains | Canaccord Genuity: Hold to Hold | 10/2/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 9/9/2024 |
| Downgrade | Benchmark: Buy to Hold | 8/26/2024 |
Related Tickers
PRVA Privia Health Group, Inc.
20.51
-2.01%
OMCL Omnicell, Inc.
42.28
-1.88%
NRC National Research Corporation
16.79
-3.17%
WAY Waystar Holding Corp.
37.49
-0.05%
PHR Phreesia, Inc.
26.68
-6.16%
SPOK Spok Holdings, Inc.
15.54
-0.45%
HSTM HealthStream, Inc.
31.38
-3.36%
DH Definitive Healthcare Corp.
4.2200
-0.24%
BTSG BrightSpring Health Services, Inc.
17.17
-0.87%
EVH Evolent Health, Inc.
12.54
-0.48%